Cancer Researchers Gain Leading-Edge Scientific Opportunities with New…
ECOG-ACRIN is official after approval of constitution.
(PRWeb May 17, 2012)
Read the full story at http://www.prweb.com/releases/2012/5/prweb9519974.htm

ECOG-ACRIN is official after approval of constitution.
(PRWeb May 17, 2012)
Read the full story at http://www.prweb.com/releases/2012/5/prweb9519974.htm
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
